HomeSearchActa Pharmaceutica Sciencia

Acta Pharmaceutica Sciencia

Istanbul Medipol University · Turkey · Est. 2016

ISSN1307-2080
SJR Q3Scopus / SJR
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗
📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q3
SJR · Scopus
Top 75% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.179
H-Indexi
10
SNIPi
0.288
Total Worksi
78
Total Citationsi
401
2yr Mean Citednessi
0.00
Open Impact Factor alternative

Aims & Scope

Acta Pharmaceutica Sciencia is an official peer-reviewed scientific journal dedicated to the advancement of pharmaceutical sciences. The journal serves as an open access platform for the publication of high-quality, interdisciplinary research across all areas of pharmacy and pharmaceutical sciences. The journal publishes original research articles and invited review papers that demonstrate conceptual novelty and scientific rigor. Areas of interest include, but are not limited to, the following: Drug design, discovery, and development, including computational drug design, molecular modeling, and in silico approaches directly contributing to drug development and pharmaceutical innovation; however, submissions consisting solely of in silico data must be integrated with robust experimental evidence to be considered for peer review Pharmacology and pharmacokinetics, encompassing molecular pharmacology, pharmacogenomics, and mechanistic studies with defined therapeutic implications Pharmaceutical technology and drug delivery systems, including advanced formulation strategies, nanotechnology-based delivery platforms, and novel carrier systems Pharmaceutical chemistry and analysis, including advanced analytical method development, validation, and quality evaluation of pharmaceutical products Pharmacognosy and phytochemistry, including nutraceuticals, functional foods, dietary supplements, and bioactivity-guided studies with translational relevance to drug development Pharmaceutical and biochemical toxicology, covering safety and toxicity evaluations of drug candidates, excipients, and natural products; mechanistic studies on adverse drug reactions; and the application of in vitro , in vivo , or in silico toxicological methods in drug development and risk assessment. Clinical and hospital pharmacy, focusing on medication management, rational drug use, therapeutic optimization, and patient-centered pharmaceutical care Regulatory sciences and pharmaceutical biotechnology, including biologics, biosimilars, and advanced pharmaceutical products relevant to pharmaceutical development Nutrition sciences, provided that studies are directly related to and complementary to pharmaceutical sciences; this includes: Nutraceuticals, functional foods, and dietary supplements investigated within a pharmaceutical, pharmacological, or clinical framework Medical nutrition therapies with demonstrated therapeutic relevance Drug–nutrient interactions and their effects on efficacy, safety, and metabolism Submissions in nutrition sciences must: Address biological, biochemical, or molecular mechanisms of action Be supported by robust experimental, translational, or clinical evidence Demonstrate clear relevance to therapeutic outcomes, patient care, or pharmaceutical development Studies outside the scope include: Research limited to general nutritional status assessment Studies focusing solely on consumer behavior, dietary habits, or preferences Descriptive or epidemiological studies lacking a pharmaceutical, pharmacological, or clinical perspective The journal particularly encourages interdisciplinary and translational research that bridges fundamental laboratory findings with pharmaceutical applications. Submissions that are not aligned with pharmaceutical relevance may be declined without external review. Review articles are typically considered by invitation or prior agreement with the editors.

General Information

Country / RegionTurkey
Primary LanguageEnglish
1st Year Published2016
Frequencyquarterly
StatusActive (last: 2021)
Total Publications78
Publisher OrgIstanbul Medipol University
Region🌍 Global South
OA Since2015
Visit Journal Website

Submission Info

Peer Reviewdouble-blind
OA LicenseCreative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

8/11 · 73%
Do you know the journal / publisher?
Istanbul Medipol University
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1307-2080
Indexed in a trusted database?
Scopus
Peer review process documented?
double-blind
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
Yes
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
29
205
2019
38
131
2020
29
85
2021
28
77
2022
28
27
2023
60
134
2024
55
17
2025
26
0
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmaceutical ScienceQ3

Subject Classification

Scopus Categories

Pharmaceutical Science

Research Topics (OpenAlex)

Synthesis and biological activityAdvanced Drug Delivery SystemsAnalytical Methods in PharmaceuticalsDrug Solubulity and Delivery SystemsNatural Antidiabetic Agents StudiesSynthesis and Characterization of Heterocyclic CompoundsComputational Drug Discovery MethodsEssential Oils and Antimicrobial ActivityMorinda citrifolia extract usesGlycosylation and Glycoproteins Research

Frequently asked questions about Acta Pharmaceutica Sciencia

Is Acta Pharmaceutica Sciencia a predatory journal?

PubScope has no integrity flags on record for Acta Pharmaceutica Sciencia: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Acta Pharmaceutica Sciencia?

Acta Pharmaceutica Sciencia is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.179.

Is Acta Pharmaceutica Sciencia indexed in Scopus and Web of Science?

Acta Pharmaceutica Sciencia is indexed in Scopus.

What is the aims and scope of Acta Pharmaceutica Sciencia?

Acta Pharmaceutica Sciencia is an official peer-reviewed scientific journal dedicated to the advancement of pharmaceutical sciences. The journal serves as an open access platform for the publication of high-quality, interdisciplinary research across all areas of pharmacy and pharmaceutical sciences. The journal publishes original research articles and invited review papers that demonstrate conceptual novelty and scientific rigor. Areas of interest include, but are not limited to, the following: Drug design, discovery, and development, including computational drug design, molecular modeling, an

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref